Hepatitis B Virus: A Molecular Perspective

被引:2
作者
Kapoor, Neetu Rohit [1 ]
Kumar, Vijay [1 ]
机构
[1] ICGEB, Virol Grp, New Delhi 110067, India
关键词
Hepatitis B virus; HBx; HCC; miRNA; HBsAg; Viral pathogenesis; Ubiquitin-proteasomal machinery; CHRONIC LIVER-DISEASE; PROTEIN INDUCES EXPRESSION; CORE PROMOTER MUTATIONS; T-CELL EPITOPES; X-PROTEIN; HEPATOCELLULAR-CARCINOMA; IN-VIVO; HBX PROTEIN; TRANSACTIVATION FUNCTION; LAMIVUDINE THERAPY;
D O I
10.1007/s40011-011-0003-z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hepatitis B virus (HBV) is a global health problem. The HBV-mediated pathogenesis is a multistep, multi-factorial event involving crucial interplay between the chronically persisting viral factors and the host system. This triggers an immune-elicited regenerative process that eventually leads to chronic liver inflammation, scarring and formation of new tissue. Further, expression of viral antigens modulates cellular signaling, nuclear transactivation and host stress-responsive pathways that produce a cumulative effect in favor of viral survival and replication. Chronic HBV infection in India affects a sizeable population and warrants more epidemiological studies in this area. There is also an urgent need to adopt new measures to limit and manage the infection in view of our low socioeconomic status and ignorance about the disease. This review highlights the role of host and viral factors in pathogenesis and outlines their underlying mechanisms. A better understanding of the viral life cycle, mode of pathogenesis and outcome of the infection should be helpful in devising new strategies to control such wide range of HBV-associated disease and developing better interventional protocols.
引用
收藏
页码:31 / 41
页数:11
相关论文
共 88 条
[41]  
Kumar A, 2009, ASIAN PAC J CANCER P, V10, P1173
[42]  
Kumar Ashish, 2005, Indian J Gastroenterol, V24, P19
[43]   A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function [J].
Kumar, V ;
Jayasuryan, N ;
Kumar, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (11) :5647-5652
[44]  
Kumar V, 2004, HANDB EXP PHARM, V166, P377
[45]   Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: A sequential pathological evaluation [J].
Lakhtakia, R ;
Kumar, V ;
Reddi, H ;
Mathur, M ;
Dattagupta, S ;
Panda, SK .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (01) :80-91
[46]   Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B [J].
Lin, CL ;
Liao, LY ;
Liu, CJ ;
Chen, PJ ;
Lai, MY ;
Kao, JH ;
Chen, DS .
JOURNAL OF GASTROENTEROLOGY, 2002, 37 (04) :283-287
[47]   Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line [J].
Liu Yan ;
Zhao Jian-Jun ;
Wang Chun-mei ;
Li Mian-yang ;
Han Ping ;
Wang Lin ;
Cheng Yong-qian ;
Fabien Zoulim ;
Ma Xu ;
Xu Dong-ping .
CHINESE MEDICAL JOURNAL, 2009, 122 (01) :10-14
[48]   HBV genotypes in India: do they influence disease severity? [J].
Madan, Kaushal ;
Batra, Yogesh ;
Sreenivas, Vishnubhatla ;
Mizokami, Masashi ;
Tanaka, Yasuhito ;
Chalamalasetty, Sreenivasa Baba ;
Panda, Subrat K. ;
Acharya, Subrat K. .
HEPATOLOGY RESEARCH, 2009, 39 (02) :157-163
[49]   In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus [J].
Malmassari, S ;
Lone, YC ;
Zhang, M ;
Transy, C ;
Michel, ML .
MICROBES AND INFECTION, 2005, 7 (04) :626-634
[50]   Expression of Pituitary Tumor-Transforming Gene 1 (PTTG1)/Securin in Hepatitis B Virus (HBV)-Associated Liver Diseases: Evidence for an HBV X Protein-Mediated Inhibition of PTTG1 Ubiquitination and Degradation [J].
Molina-Jimenez, Francisca ;
Benedicto, Ignacio ;
Murata, Miki ;
Martin-Vilchez, Samuel ;
Seki, Toshihito ;
Antonio Pintor-Toro, Jose ;
Tortolero, Maria ;
Moreno-Otero, Ricardo ;
Okazaki, Kazuichi ;
Koike, Kazuhiko ;
Luis Barbero, Jose ;
Matsuzaki, Koichi ;
Majano, Pedro L. ;
Lopez-Cabrera, Manuel .
HEPATOLOGY, 2010, 51 (03) :777-787